Clinical Trials List
Protocol NumberKER-012-A201
Completed
2023-10-02 - 2026-11-01
Phase II
Recruiting2
ICD-10I27.0
Primary pulmonary hypertension
ICD-9416.0
Primary pulmonary hypertension
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- 林坤璋 Division of General Internal Medicine
- 王美慈 Division of General Internal Medicine
- 江承鴻 Division of Cardiovascular Diseases
- 楊弘州 無
- 楊國銘 Division of Cardiovascular Diseases
- 黃偉春 Division of Cardiovascular Diseases
- 楊弘州 Division of General Internal Medicine
- 郭書宏 Division of General Internal Medicine
- 林肅強 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
90 participants
